Drawing for NMDP FIND CURES. SAVE LIVES.

USPTO serial 97864396

NMDP FIND CURES. SAVE LIVES.

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BURCH, JILLIAN RENEE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NMDP FIND CURES. SAVE LIVES.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KOURTNEY A. MULCAHY

KOURTNEY A. MULCAHY AKERMAN LLP777 SOUTH FLAGLER DRIVESUITE 1100 WEST TOWERWEST PALM BEACH, FL 33401

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for scientific research use, namely, for developing new cellular therapies and other treatmentsABANDONED—
005Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for medical purposesABANDONED—
035Logistics management in the medical field, namely, management and coordination of medical services related to bone marrow and stem cell donation; Transportation logistics services, namely, arranging for the transportation of goods for others, particularly of products and samples from a collection site to entities who are developing new cellular therapies and other treatments related to bone marrow and peripheral blood stem cells; Charitable services, namely, organizing and conducting volunteer programs and community service projects related to bone marrow, peripheral blood stem cells and cord blood donation; Promoting awareness of the need for bone marrow, peripheral blood stem cells and cord blood donation; Maintaining and operating a central bone marrow registry for use in matching potential donors and recipients for bone marrow and hematopoietic stem cell transplant; Promoting awareness of the need for bone marrow donors by organizing and conducting bone marrow donor registry drives being volunteer programs and community service projects to increase registered donorsABANDONED—
036Charitable fundraising services, namely, raising funds for bone marrow, peripheral blood stem cells and cord blood research, transplant services, educational programs and donor recruitment; Providing financial assistance to patients and their families in the need of bone marrow, peripheral blood stem cells and cord blood transplantsABANDONED—
041Educational and training services, namely, providing seminars, workshops, conferences, classes, lectures and presentations in the field of stem cells, stem cell research and stem cell applications and cellular therapies and distribution of course and educational materials in connection therewith; On-line electronic newsletters delivered by email in the field of stem cell, cord blood and bone marrow donationsABANDONED—
042Providing medical research services for developing new cellular therapies and other treatments in the field of bone marrow and peripheral blood stem cells; Gene therapy researchABANDONED—
044Providing a website featuring healthcare information on stem cell and bone marrow donor recruitment and donation; Providing an Internet website portal featuring information relating to bone marrow transplant procedures; Providing information in field of cellular therapies, bone marrow and hematopoietic stem cell transplants and stem cell therapy services; Stem cell therapy servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2026MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Sep 18, 2026ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 18, 2026OP.TOPPOSITION TERMINATED NO. 999999—
Sep 18, 2026OP.DOPPOSITION DISMISSED NO. 999999—
Aug 6, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 6, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 6, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 28, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 28, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 28, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 28, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2023DOCKASSIGNED TO EXAMINER—
Apr 23, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 3, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance